uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
24.83
-0.47 (-1.86%)
At close: Oct 30, 2026, 4:00 PM EST
27.46
+2.63 (10.59%)
Pre-market: Nov 2, 2026, 7:13 AM EST
uniQure Market Cap
uniQure has a market cap or net worth of $1.72 billion as of October 30, 2026. It is the 7,145th most valuable company in the world and the 1,869th biggest in the United States. Its market cap has decreased by 55.53% in one year.
Market Cap
1.72B
Enterprise Value
1.46B
1-Year Change
-55.53%
Global Rank
Country Rank
#1,869 United States
Category
ChartMarket Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $1.72B, an increase of 969.13%. That is a compound annual growth rate of 27.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.72B | 15.55% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.85B |
| Agios Pharmaceuticals | 1.82B |
| Braveheart Bio | 1.76B |
| Intellia Therapeutics | 1.75B |
| Maze Therapeutics | 1.70B |
| Stoke Therapeutics | 1.70B |
| Nuvation Bio | 1.67B |
| Replimune Group | 1.67B |